speb/financial-data huggingface dataset:
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 71996800000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 16629100000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 125167600000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Investment Properties: 624100000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 14162000000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 36500000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 5612000000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 5648500000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 382700000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 29861700000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 71996800000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 93959900000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 3267200000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 193317190.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 5180400000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 2997900000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 93600600000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 4799600000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 901800000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 63335200000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 93200000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 16603300000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Payables: 9454200000.00
BALKRISIND.NS income_statement (quarterly, 2024-09-30) — Selling And Marketing Expense: 1831900000.00
BALKRISIND.NS income_statement (quarterly, 2024-09-30) — Selling General And Administration: 1831900000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 193317190.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 93987200000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 93959900000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 145014900000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 99599200000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 31216900000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 93987200000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 51027700000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 91609800000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 11392500000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 259000000.00
BALKRISIND.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 13769900000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 8994300000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 25603300000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 193324731.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 23.25
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 12328000000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 1725900000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 1725900000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 193324731.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 23.25
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 4494800000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — EBIT: 6153900000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — EBITDA: 7879800000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 13275300000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 157100000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 157100000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Net Income: 4494800000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 4494800000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 4494800000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 4494800000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 4494800000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 4494800000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -157100000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -157100000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 7879800000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 4494800000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Operating Income: 4281000000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 25603300000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 1872900000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 5821100000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 5996800000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 12328000000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 1725900000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 1614400000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Selling General And Administration: 1614400000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 1502000000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.25
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 21322300000.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
BALKRISIND.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — +Operating Expense: 32203000000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 9384900000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — +Total Revenue: 103572400000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 27523800000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 7539300000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 7539300000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 14945400000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 14945400000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -43167200000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -43167200000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 6573100000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 6573100000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 193317190.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 193363064.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Basic EPS: 85.61
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 19.06
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 746200000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 22757800000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 22757800000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -14830000000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 49000000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 49000000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 386600000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 386600000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 802400000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 802400000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 17830200000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 17830200000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -3095100000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 802400000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 802400000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -4504000000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -6300000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Change In Payable: -1026700000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 1047200000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -4489800000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 57400000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Common Stock: 386600000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 386600000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 103876000000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 103876000000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 0.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 14369000000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 14369000000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 53582500000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 13786100000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Current Assets: 55714000000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 55714000000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 3500000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 3500000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Current Debt: 28752500000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 28752500000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 28756000000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 28756000000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 42266500000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 42266500000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 50700000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 50700000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Depreciation: 6806600000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 6806600000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 6806600000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 1782300000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 6806600000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 1782300000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Derivative Product Liabilities: 204700000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 204700000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 193317190.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 193363064.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Diluted EPS: 85.61
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 19.06
BALKRISIND.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 16549600000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 3685500000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 28100000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 28100000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — EBIT: 22969300000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — EBIT: 5346500000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — EBITDA: 29775900000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — EBITDA: 7128800000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: -1200000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — End Cash Position: 802400000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Financial Assets: 840000000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets: 840000000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 9042600000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 9042600000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -2790100000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 5714900000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 5714900000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 2811400000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -1832300000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -83000000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 1221000000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 37300000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 37300000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 126296900000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 126296900000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Gross Profit: 49989900000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 13737700000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 751200000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 751200000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Interest Expense: 1095400000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 495000000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 1095400000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 495000000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Interest Income: 633600000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 633600000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -1126900000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 663400000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Inventory: 17819300000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 17819300000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 136501500000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 136501500000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -14793900000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 612400000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 612400000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 15615700000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 15615700000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 0.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 24610600000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 1653400000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 1653400000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 45500000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 45500000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 3873000000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 3873000000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 3918500000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 3918500000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 24610600000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -36470600000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 483600000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 483600000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 82365900000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 82365900000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 0.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Net Debt: 31823100000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 31823100000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -214600000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Net Income: 16549600000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Net Income: 3685500000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 16549600000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 3685500000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 16549600000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 3685500000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 16549600000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 3685500000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 16549600000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 3685500000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 21873900000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 16549600000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 3685500000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Net Interest Income: -486000000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -495000000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -1760300000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 1432900000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -11860000000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -486000000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -495000000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 785100000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Net PPE: 83129700000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 83129700000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -14484100000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 13292900000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 103838700000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 103838700000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 1029400000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 1029400000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 4563000000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 4563000000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 209600000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 209600000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 27980300000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 7128800000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Normalized Income: 15191066996.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 3685500000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 17641400000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Operating Income: 17786900000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Operating Income: 4352800000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Operating Revenue: 103572400000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 27523800000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 193317190.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 193317190.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 4057000000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 4057000000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 594300000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 594300000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 103489400000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 103489400000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 37300000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 37300000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 144000000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 144000000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 415400000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 4530100000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 4530100000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 100000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 100000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 149900000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 993700000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 5575700000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 6105700000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Other Payable: 3037600000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 3037600000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Other Properties: 5150800000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 5150800000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 249300000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 249300000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 17027800000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 17027800000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Other Special Charges: -82600000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Payables: 10605000000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Payables: 10605000000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: -53300000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 50700000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 50700000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 2286800000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 2286800000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Pretax Income: 21873900000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 4851500000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: -2000000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -27760300000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -14830000000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 10081600000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 10081600000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 53582500000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 13786100000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 6806600000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1782300000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 132500000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 132500000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -36470600000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 60100000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 60100000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 44182300000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 44182300000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 26000000000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 345900000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 11226800000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 6000400000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 12447800000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 7221400000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Share Issued: 193317190.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 193317190.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Special Income Charges: 82600000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 103876000000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 103876000000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 103838700000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 103838700000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 437066996.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Tax Provision: 5324300000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 1166000000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.24
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.24
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 1771700000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 1771700000.00
BALKRISIND.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -4832800000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Total Assets: 156346600000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 156346600000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 107749000000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 107749000000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Total Debt: 32674500000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 32674500000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 103876000000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 103876000000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Total Expenses: 85785500000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 23171000000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 52470600000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 52470600000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 100632600000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 100632600000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 10204100000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 10204100000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 24200000.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 1795600000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
BALKRISIND.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 1795600000.00
BALKRISIND.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Work In Process: 1878800000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 1878800000.00
BALKRISIND.NS balance_sheet (annual, 2025-03-31) — Working Capital: 13447500000.00
BALKRISIND.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 13447500000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 11056900000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 27600200000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 193360161.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 14.91
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 13363000000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 1881700000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 1881700000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 193360161.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 14.91
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 2883000000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — EBIT: 4251700000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — EBITDA: 6133400000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 14237200000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 307900000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 307900000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Net Income: 2883000000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 2883000000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 2883000000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 2883000000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 2883000000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 2883000000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -307900000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -307900000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 6133400000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 2883000000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Operating Income: 3180300000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 27600200000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 1071400000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 7691000000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 3943800000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 13363000000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1881700000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 1060800000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.27
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 24419900000.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
BALKRISIND.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 9590400000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 27367900000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 193297926.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 19.77
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 13300500000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 1953400000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 1953400000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 193297926.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 19.77
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 3821500000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — EBIT: 5251100000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — EBITDA: 7204500000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 14067400000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 340500000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 340500000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Net Income: 3821500000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 3821500000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 3821500000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 3821500000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 3821500000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 3821500000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -340500000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -340500000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 7204500000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 3821500000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Operating Income: 4477000000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 27367900000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 774100000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 6176700000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 4910600000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 13300500000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1953400000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 1089100000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.22
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 22890900000.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
BALKRISIND.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BALKRISIND.NS income_statement (annual, 2026-03-31) — +Operating Expense: 34237400000.00
BALKRISIND.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 10831200000.00
BALKRISIND.NS income_statement (annual, 2026-03-31) — +Total Revenue: 107296100000.00
BALKRISIND.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 29328200000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 9122600000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 9122600000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 14465700000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 14465700000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -50945900000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -50945900000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 7539300000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 7539300000.00
BALKRISIND.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 193317190.00
BALKRISIND.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 193324726.00
BALKRISIND.NS income_statement (annual, 2026-03-31) — Basic EPS: 64.30
BALKRISIND.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 15.49
BALKRISIND.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 802400000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 24346600000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 24346600000.00
BALKRISIND.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -30032900000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 52600000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 52600000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 386600000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 386600000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 609200000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 609200000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 13884000000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 13884000000.00
BALKRISIND.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -3091900000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 609200000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 609200000.00
BALKRISIND.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -265400000.00
BALKRISIND.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 24300000.00
BALKRISIND.NS cash_flow (annual, 2026-03-31) — Change In Payable: 2140800000.00
BALKRISIND.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 20800000.00
BALKRISIND.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 1920500000.00
BALKRISIND.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -194200000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Common Stock: 386600000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 386600000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 109552900000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 109552900000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 33464000000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 33464000000.00
BALKRISIND.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 54901600000.00
BALKRISIND.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 14086000000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Current Assets: 51544700000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 51544700000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 11900000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 11900000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Current Debt: 32175600000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 32175600000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 32187500000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 32187500000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 50890000000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 50890000000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 60100000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 60100000.00
BALKRISIND.NS cash_flow (annual, 2026-03-31) — Depreciation: 7749600000.00
BALKRISIND.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 7749600000.00
BALKRISIND.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 7749600000.00
BALKRISIND.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 1988600000.00
BALKRISIND.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 7749600000.00
BALKRISIND.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 1988600000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Derivative Product Liabilities: 2792600000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 2792600000.00
BALKRISIND.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 193317190.00
BALKRISIND.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 193324726.00
BALKRISIND.NS income_statement (annual, 2026-03-31) — Diluted EPS: 64.30
BALKRISIND.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 15.49
BALKRISIND.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 12431000000.00
BALKRISIND.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 2994600000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 29200000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 29200000.00
BALKRISIND.NS income_statement (annual, 2026-03-31) — EBIT: 17505500000.00
BALKRISIND.NS income_statement (quarterly, 2026-03-31) — EBIT: 4371800000.00
BALKRISIND.NS income_statement (annual, 2026-03-31) — EBITDA: 25255100000.00
BALKRISIND.NS income_statement (quarterly, 2026-03-31) — EBITDA: 6360400000.00
BALKRISIND.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 1000000.00
BALKRISIND.NS cash_flow (annual, 2026-03-31) — End Cash Position: 609200000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Financial Assets: 170800000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Financial Assets: 170800000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 10425500000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 10425500000.00
BALKRISIND.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 2542400000.00
BALKRISIND.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 6296700000.00
BALKRISIND.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 6296700000.00
BALKRISIND.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -7539700000.00
BALKRISIND.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -1876500000.00